4-6923705-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020773.3(TBC1D14):c.316G>A(p.Ala106Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020773.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBC1D14 | NM_020773.3 | c.316G>A | p.Ala106Thr | missense_variant | 2/14 | ENST00000409757.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBC1D14 | ENST00000409757.9 | c.316G>A | p.Ala106Thr | missense_variant | 2/14 | 1 | NM_020773.3 | ||
TBC1D14 | ENST00000448507.5 | c.316G>A | p.Ala106Thr | missense_variant | 2/14 | 5 | |||
TBC1D14 | ENST00000444368.1 | c.316G>A | p.Ala106Thr | missense_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250930Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135744
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461460Hom.: 0 Cov.: 32 AF XY: 0.0000220 AC XY: 16AN XY: 727056
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.0000805 AC XY: 6AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2023 | The c.316G>A (p.A106T) alteration is located in exon 2 (coding exon 1) of the TBC1D14 gene. This alteration results from a G to A substitution at nucleotide position 316, causing the alanine (A) at amino acid position 106 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at